Coeptis Therapeutics, Inc.

NASDAQ:COEP

Biotechnology

Healthcare
$14.64 +4.68%

+$0.73 today

Market cap
$57.63M
Beta
-0.43
P/E (TTM)
-8.3
EPS (TTM)
-$1.97
52W Low $6.80High $21.41

Volume 0.18M

Average 0.05M

Balance Sheet

Inspect the capital base behind the business.

Assets

$19.84M

FY 2025 · Annual

+122.7% YoY

Liabilities

$2.09M

FY 2025 · Annual

-58.6% YoY

Equity

$17.75M

FY 2025 · Annual

+359.1% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents2.18M3.79M1.47M532.89K5.67M
Short-term Investments0000676.6K
Net Receivables08.08K38.98K07.35K
Inventory00000
Other Current Assets00000
Total Current Assets2.18M3.94M1.75M1.05M7.35M
Property, Plant & Equipment (Net)31.85K71.46K108.88K59.78K18.4K
Goodwill00000
Intangible Assets4.55M3.55M2.55M541.88K361.25K
Long-term Investments003.5M5.69M7.86M
Tax Assets00000
Other Non-current Assets4.55M348.33K158.33K1.56M4.25M
Total Non-current Assets4.59M3.97M6.32M7.86M12.49M
Total Assets6.77M7.92M8.07M8.91M19.84M
Account Payables134.09K99.02K1.42M1.27M888.76K
Short-term Debt2.42M1.89M1.01M1.19M118.88K
Tax Payables00000
Deferred Revenue0000599.46K
Other Current Liabilities199.13K182K555.95K1.28M161.05K
Total Current Liabilities2.76M2.17M2.99M4.51M1.77M
Long-term Debt1.65M150K150K150K150K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities01.13M557.25K359.25K167.63K
Total Non-current Liabilities1.65M1.29M768.43K528.13K317.63K
Total Liabilities4.41M3.46M3.76M5.04M2.09M
Common Stock3.55K1.96K3.53K212575
Retained Earnings(27.55M)(66.09M)(87.36M)(98.23M)(109.95M)
Accumulated OCI00000
Other Stockholders Equity000(1.56M)0
Minority Interest000682.06K506.16K
Total Equity2.35M4.45M4.31M3.87M17.75M
Total Debt4.08M2.06M1.22M1.4M268.88K
Net Debt1.9M(1.73M)(244.91K)866.17K(5.41M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$5.2M
Short-term Investments$50.6K
Receivables$15.3K
Other Current$631.1K
Total Current Assets$5.9M
PP&E (Net)$89.3K
Intangible Assets$316.1K
Long-term Investments$13.2M
Other Non-current$313.9K
Total Non-current Assets$13.9M
Total Assets$19.8M

Analysis

Selected assets total $19.8M for Latest. The largest visible component is Long-term Investments at $13.2M, about 66.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B3424B3 filingJun 18, 2026
EFFECTEFFECT filingJun 16, 2026
POS AMPOS AM filingJun 16, 2026
S-1S-1 filingJun 9, 2026
4Statement of changes in beneficial ownershipJun 8, 2026

How much cash does COEP have?

Coeptis Therapeutics, Inc. (COEP) reported $5.67M in cash and equivalents in fiscal 2025.

How much debt does COEP carry?

Coeptis Therapeutics, Inc. (COEP) reported $268,875.00 of total debt, with net debt of -$5.41M.